EDGAR Filing Documents for 0001477932-20-004521

Form 8-K - Current report:

SEC Accession No. 0001477932-20-004521

Filing Date

2020-08-04

Accepted

2020-08-04 09:29:28

Documents

Period of Report

2020-07-31

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	ipix_8k.htm	8-K	22530
2	REGISTRATION RIGHTS AGREEMENT	ipix_ex41.htm	EX-4.1	68619
3	OPINION	ipix_ex51.htm	EX-5.1	9761
4	COMMON STOCK PURCHASE AGREEMENT	ipix_ex101.htm	EX-10.1	159360
5	PRESS RELEASE	ipix_ex991.htm	EX-99.1	11396
	Complete submission text file	0001477932-20-004521.txt		273072

Mailing Address 301 EDGEWATER PLACE SUITE 100 WAKEFIELD MA 01880

Business Address 301 EDGEWATER PLACE SUITE 100 WAKEFIELD MA 01880 978-921-4125

Innovation Pharmaceuticals Inc. (Filer) CIK: 0001355250 (see all company filings)

IRS No.: 300565645 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-37357 | Film No.: 201071425
SIC: 2834 Pharmaceutical Preparations